Adolescent obesity contributes to endometrial cancer risk in women

Study led by the Cancer Prevention Institute of California finds women obese over a prolonged period are at greatest risk

While it is well established that obesity is closely linked to endometrial cancer risk, most past findings have only looked at risk in relation to one measure of body size at a time. In this study led by the Cancer Prevention Institute of California, e-published on November 3, 2016 in the journal Cancer Causes and Control, researchers evaluated changes in obesity, beginning at adolescence, to identify lifetime risk factors that may lead to endometrial cancer.

Researchers found that adolescent obesity contributed to endometrial cancer risk, even among women who were at a normal weight as adults. However, women who were obese over a prolonged period were at greatest risk. Further, the taller the woman, the greater the risk associated with prolonged obesity. These associations are limited to women who have not used any form of hormone therapy. Among women using hormone therapy, only greater height was associated with risk.

According to Pamela Horn-Ross, the lead researcher of this study and consulting epidemiologist with the Cancer Prevention Institute of California:

The results of this study have important implications for the future risk of endometrial cancer among girls given the widespread epidemic of obesity in our society. It will also help researchers understand discrepancies between previous studies and aid in developing targeted inventions for the prevention of endometrial cancer.

To conduct this study, researchers evaluated 88,142 female participants in the California Teachers Study (CTS) followed for more than 15 years. Participants completed a self-administered questionnaire addressing health and medical history, including hormone therapy and body size, at the time they began participation in the study group and repeated three more surveys through 2006. Only women who had not had an endometrial cancer prior to joining the study were included in this analysis. Of the study participants, 887 were diagnosed with invasive type I endometrial cancer between 1997 and 2012.

The CTS is a statewide health study of over 133,000 female current and former school teachers and school administrators that started in 1995. Along with the Cancer Prevention Institute of California, other participating research institutions are the City of Hope National Medical Center, the University of Southern California, and the University of California, Irvine.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mainz Biomed seeks FDA’s Breakthrough Devices Designation for advanced colorectal cancer test